Navigation Links
Notre Dame researchers develop system that uses a big data approach to personalized healthcare
Date:7/25/2013

t the core premise of CARE is centered on patient empowerment and patient engagement.

"Imagine visiting your physician's office with a list of concerns and questions," he said. "What if you could walk out of the office with a personalized assessment of your health, along with a list of personalized and important lifestyle change recommendations based on your predicted health risks? What if your physician was afforded a limitless experience to gauge the impact of your disease toward developing other diseases in the future? What if you could find out that there are other patients similar to you not only with respect to major symptoms, but also with respect to rare issues that have puzzled your doctor? What if you could have the experience of others at your fingertips and fathom the lifestyle changes warranted for mitigating diseases?"

Chawla believes the timing is right for CARE given changes in health care, reimbursement, reform, meaningful use of electronic health care data and a mandate for patient-centered outcomes.

"The industry is seeing a move toward health and wellbeing and how that can be personalized to an individual," he said. "There is an increased focus on preventative care, wellbeing and reducing re-admission rates in the hospital. This system can help bend the cost curve."

CARE has been awarded a U.S. patent.


'/>"/>

Contact: Nitesh Chawla
nchawla@nd.edu
574-631-1090
University of Notre Dame
Source:Eurekalert

Page: 1 2

Related biology news :

1. Notre Dame study finds Asian carp DNA not widespread in the Great Lakes
2. Notre Dame researcher is studying role small dams play in pollution control
3. Notre Dame researchers are using new technologies to combat invasive species
4. Notre Dame research may have important implications for combating diabetes
5. Cargill expands support of Notre Dame Haiti Program
6. Notre Dame research reveals migrating Great Lakes salmon carry contaminants upstream
7. Notre Dame research could improve sustainability and cost effectiveness of wastewater treatment
8. Notre Dame research could provide new insights into tuberculosis and other diseases
9. Notre Dame researcher is shedding light on how jaws evolve
10. Notre Dame establishes professorships in adult stem cell research
11. Notre Dame researchers using novel method to combat malaria drug resistance
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/9/2015)... , July 9, 2015  Synaptics ... developer of human interface solutions, today announced ... industry,s first fully hardware encapsulated fingerprint sensor ... authentication technology is literally off the grid, ... biometric matching within the fingerprint sensor to ...
(Date:7/7/2015)... , June 30, 2015 ... has announced the addition of the "Capacitive ... offering. To this date, fingerprint sensing ... technology and fingerprint sensors are well developed. This ... sensing technology. The domain of capacitive ...
(Date:7/2/2015)... -- Fingerprint Cards has received an order for ... the distributor World Peace Industrial Group (WPI), part of WPG ... Asia . Deliveries are planned to take place during ... smartphone manufacturers in Asia . The order ... guidance of approximately 2,200 MSEK for 2015. Jörgen ...
Breaking Biology News(10 mins):Synaptics Announces World's First Match-in-Sensor Fingerprint Authentication Technology 2Synaptics Announces World's First Match-in-Sensor Fingerprint Authentication Technology 3Worldwide Capacitive Fingerprint Sensors Patent Landscape Market Report 2015-2020 - Main IP Holders include Seiko Epson, AuthenTec, Sony and STMicroelectronics 2FPC Receives Order for Touch Fingerprint Sensors of 268 MSEK 2
... BOSTON Congenital heart diseases affect approximately one ... of birth defect and the number-one cause of pediatric deaths. ... inhibitor drug rapamycin can reverse cardiac muscle damage in a ... identifies the first possible medical treatment for this rare condition, ...
... Climate change is already having an effect on the ... taken it,s only going to get worse, a Michigan State ... the American Association for the Advancement of Science. Ewen ... organized a session titled "How Climate Change Affects the Safety ...
... attention has focused on issues such as the challenges ... pharmaceutical companies have invested comparatively little effort in updating ... inefficient, under-utilized and ill-equipped to cope with new medicines, ... latest report in the Pharma 2020 series, ...
Cached Biology News:Study shows rapamycin reverses myocardial defects in mouse model of LEOPARD syndrome 2Study shows rapamycin reverses myocardial defects in mouse model of LEOPARD syndrome 3Pharmaceutical Supply Chains Are Due for a Radical Overhaul Says PwC 2Pharmaceutical Supply Chains Are Due for a Radical Overhaul Says PwC 3Pharmaceutical Supply Chains Are Due for a Radical Overhaul Says PwC 4Pharmaceutical Supply Chains Are Due for a Radical Overhaul Says PwC 5
(Date:7/30/2015)... and Dallas, TX, USA (PRWEB) , ... July ... ... innovative nano and microsystems, has appointed Francois Vieillard as Sales & Marketing Director. ... at executive positions, Francois Vieillard will be responsible for reinforcing Tronics’ business development ...
(Date:7/30/2015)... July 30, 2015   Aratana Therapeutics, Inc ... company focused on the licensing, development and commercialization ... announced that its strategic partner VetStem Biopharma, Inc. ... study of AT-016, an adipose-derived allogeneic stem cell ... of osteoarthritis pain in dogs. The ...
(Date:7/30/2015)... HIGHLIGHTS:Q2 2015 Results (all changes ... Reported sales were $697 million compared to $701 million ... by 8%, and changes in foreign currency exchange rates ... 1%. , By business unit, organic sales growth ... in SAFC Commercial. , Reported diluted EPS was ...
(Date:7/29/2015)... Sanofi, a global and ... quarter of 2015. CEO Olivier Brandicourt ... in different businesses. Watch video interview ... Topics covered in the interview include:  ... Performance drivers - Diabetes ...
Breaking Biology Technology:Tronics appoints Francois Vieillard as Sales and Marketing Director 2Aratana Therapeutics Announces Positive Pilot Field Study for AT-016 2Aratana Therapeutics Announces Positive Pilot Field Study for AT-016 3Aratana Therapeutics Announces Positive Pilot Field Study for AT-016 4Aratana Therapeutics Announces Positive Pilot Field Study for AT-016 5Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 2Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 3Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 4Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 5Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 6Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 7Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 8Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 9Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 10Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 11Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 12Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 13Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 14Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 15Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 16Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 17Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 18Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 19Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 20
... , , , ... leading systems biology tools company, announced today that they ... International Society for Interferon and Cytokine Research (www.isicr.org). These ... and chemical pathway interactions. Each map describes multi-step signaling ...
... SYDNEY, July 21 /PRNewswire-Asia/ -- Pharmaxis Ltd (ASX: ... the afternoon of Wednesday,22nd July 2009. Dr Alan Robertson ... quarter and answer investor questions. , ... (Sydney),(Wednesday 22nd July at 6.00pm U.S. East Coast, 3.00pm U.S. ...
... Guo and his team of researchers for the project discovered a ... is pitch black, not by paint, but by using incredibly intense ... that shines upon it. "With the creation of the ... us, which may open up a whole new horizon for various ...
Cached Biology Technology:GeneGo Donates Proprietary Cytokine Pathway Maps to ISICR 2Laser technology creates new forms of metal and enhances aircraft performance 2
CASPR (H-66)...
Mouse monoclonal [PRMT5-21] to PRMT5 ( Abpromise for all tested applications). entrezGeneID: 10419 SwissProtID: O14744...
Mouse Nodal Affinity Purified Polyclonal Ab...
Normal sheep serum collected from healthy normal sheep...
Biology Products: